Brief: China Pioneer Pharma Holdings Posts Net Profit Rmb140.8 Million In 2021
March 31 (Reuters) - China Pioneer Pharma Holdings Ltd
1345.HK :
* NET PROFIT INCREASED BY 173.5% TO RMB140.8 MILLION IN 2021
* FOR YEAR REVENUE INCREASED BY 7.7% TO RMB1,434.8 MILLION
* FINAL DIVIDEND OF HK$0.064 PER SHARE HAS BEEN PROPOSED
Further company coverage: 1345.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Pioneer Holding
See all newsBrief: Shanghai Pioneer Posts HY Revenue Rmb602.8 Million
Brief: Shanghai Pioneer Net Profit Rmb105.1 Million In 2025
Brief: Shanghai Pioneer To Be Exclusive Distributor Of Labo Hair Loss Vials In China
Brief: Shanghai Pioneer Logs H1 Gross Profit RMB 303 Mln
Brief: Shanghai Pioneer Expects 45%-48% Net Profit Decrease For HY